Philina Lee - 13 Mar 2024 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Signature
/s/ Melissa Masse, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
13 Mar 2024
Net transactions value
-$702,302
Form type
4
Filing time
15 Mar 2024, 16:47:12 UTC
Previous filing
11 Mar 2024
Next filing
04 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $4,602 +523 +1.3% $8.80 41,528 13 Mar 2024 Direct
transaction BPMC Common Stock Options Exercise $18,372 +1,224 +2.9% $15.01 42,752 13 Mar 2024 Direct
transaction BPMC Common Stock Sale $563,493 -6,223 -15% $90.55 36,529 13 Mar 2024 Direct F1
transaction BPMC Common Stock Sale $161,784 -1,800 -4.9% $89.88 34,729 13 Mar 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.16 to $91.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2).
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $89.53 to $90.15.